| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 09/24/2008 | EP1971600A1 Isoxazole derivatives and use thereof |
| 09/24/2008 | EP1971599A1 Antiviral 2-carboxy-thiophene compounds |
| 09/24/2008 | EP1971598A1 Beta-secretase modulators and methods of use |
| 09/24/2008 | EP1971597A2 N-(5-membered heteroaromatic ring)-amido anti-viral compounds |
| 09/24/2008 | EP1971596A2 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands |
| 09/24/2008 | EP1971594A2 Substituted pyrazalones |
| 09/24/2008 | EP1971582A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 09/24/2008 | EP1971580A1 Piperazine compounds with a herbicidal action |
| 09/24/2008 | EP1723116B1 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
| 09/24/2008 | EP1537096B1 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 09/24/2008 | CN101273042A Macrocyclic inhibitors of hepatitis C virus |
| 09/24/2008 | CN101273037A New compounds for the treatment of neurological, psychiatric or pain disorders |
| 09/24/2008 | CN101273036A Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| 09/24/2008 | CN101273033A 4- (iH-indazol-s-yl-amino)-quinazoline compounds as ERBB receptor tyrosine kinase inhibitors for the treatment of cancer |
| 09/24/2008 | CN101273029A Bicyclic bisamide derivatives and use thereof as insecticides |
| 09/24/2008 | CN101273028A Macrocyclic inhibitors of hepatitis C virus |
| 09/24/2008 | CN101273016A Antibacterial quinoline derivatives |
| 09/24/2008 | CN101272784A Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
| 09/24/2008 | CN101272783A (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor |
| 09/24/2008 | CN101270117A Herbicide and preparation thereof |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427636 Hepatitis C; toxicity, side effects reduction; improved pharmacological/pharmacokinetics properties; novel intermediates; increased cellular accumulation and retention of a drug compound, to improve their therapeutic and diagnostic value, comprising linking the compound to one or more phosphonate groups |
| 09/23/2008 | US7427620 4-{4-[4-{4-[2-(2-pyridinyl)-2-(1 H-1,2,4-triazol- 1 -yl-methyl)- 1 ,3-dioxolan-4-yl-methoxy]phenyl}- 1-piperazinyl]-phenyl}-2-( 1-methyl)-propyl-2,4-dihydro-3H-1,2,4-triazol-3-one; better toxicological profile and of reduced interaction with other drugs; good solubility in water, bioavailability |
| 09/23/2008 | US7427618 e.g. 2-[3-(4-ethynylphenyl)ureido]-N-[4-(3-oxomorpholin-4-yl)phenyl]valeramide; anticoagulant, antitumor factor; thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty, claudicatio intermittens, or migraine |
| 09/23/2008 | US7427617 e.g. 2-[1-(2-Fluorobenzyl)-1H-indazol-3-yl]-5-(3-oxa-9-azabicyclo[3.3.1]non-9-yl)-4pyrimidinylamine; soluble guanylate cyclase stimulant; neurodegenerative diseases, cognition activator; Alhzeimer's, Parkinson's disease, Pick's syndrome, multiple sclerosis, HIV dementia, schizophrenia |
| 09/23/2008 | US7427615 3-substituted-4-pyrimidone derivatives |
| 09/23/2008 | US7427608 Protection against and treatment of hearing loss |
| 09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |
| 09/23/2008 | CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 09/23/2008 | CA2337825C Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions |
| 09/23/2008 | CA2293373C Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 09/18/2008 | WO2008112900A1 Dibenzo[b,f][1,4]oxazapine compounds |
| 09/18/2008 | WO2008112022A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors |
| 09/18/2008 | WO2008111300A1 Novel diamide derivative |
| 09/18/2008 | WO2008111299A1 Novel diamide derivative |
| 09/18/2008 | WO2008110534A1 Pharmaceutical compositions of poorly soluble drugs |
| 09/18/2008 | WO2008109994A1 Inhibitors of histone deacetylase |
| 09/18/2008 | WO2008109991A1 Inhibitors of carnitine palmitoyltransferase and treating cancer |
| 09/18/2008 | WO2008109943A1 Phenyl amino pyrimidine compounds and uses thereof |
| 09/18/2008 | WO2008082637A9 Composition and methods for modulating a kinase cascade |
| 09/18/2008 | WO2007090068A3 Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif) |
| 09/18/2008 | US20080227839 Kinase Inhibitors |
| 09/18/2008 | US20080227833 Selective inhibitors of MMP-9 and/or MMP12; antiinflammatory agents for multiple sclerosis and fibrosis; 3R-[2,2-Dimethyl-1 S-(5-phenyl-[1,2,4]oxadiazol-3-yl)-propylcarbamoyl]-2S-hydroxy-5-methyl-hexanohydroxamic acid; bone resorption, metastases, rheumatoid arthritis, Crohn's disease |
| 09/18/2008 | US20080227824 5-(Phenylisoxazolylethoxy) - Triazol- 3 -Yl Substituted Pyridine Compounds for the Treatment of Neurological, Psychiatric or Pain Disorders |
| 09/18/2008 | US20080227793 2-(1-Imidazomethyl)- or 2-(1-imidazooxy)-substituted, e.g., 6-chloro-2-{[2-(2-fluorophenyl)-1H-imidazol-1-yl]methyl}-1-propyl1H-benzimidazole; GABA receptor signal transduction; anxiety, antidepressants, sleep disorders, schizophrenia, attention deficit-hyperactivity disorder, memory enhancement |
| 09/18/2008 | US20080227785 BEC 1 potassium channel inhibitors, used to treat dementia and learning disorders; e.g., N-(4-fluorophenyl)-N'-isopropyl-N''-phenyl-1,3,5-triazine-2,4,6-triamine hydrochloride |
| 09/18/2008 | US20080227783 5-Substituted Thiazol-2-Yl Amino Compounds and Compositions as Protein Kinase Inhibitors |
| 09/18/2008 | US20080227782 Pyrimidine amide compounds as pgds inhibitors |
| 09/18/2008 | US20080227781 Imidazole compounds for the treatment of neurodegenerative disorders |
| 09/18/2008 | US20080227780 Soluble epoxide hydrolase inhibitors |
| 09/18/2008 | US20080227779 6-chloro-N-(pyrimidin-5-yl)-3-(3-(trifluoromethyl)phenylamino)benzo[d]isoxazole-7-carboxamide; autoimmune disease, allergies, mastcytosis, mast cell related tumors and various fibrotic diseases |
| 09/18/2008 | US20080227778 6-Methoxy-3-(methoxymethyl)-2-methyl-4-phenylisoquinolin-1(2H)-one; treat cardiac arrhythmias |
| 09/18/2008 | US20080227775 Quinoline Derivatives as Antibacterial Agents |
| 09/18/2008 | CA2702650A1 Phenyl amino pyrimidine compounds and uses thereof |
| 09/18/2008 | CA2680467A1 Inhibitors of histone deacetylase |
| 09/18/2008 | CA2680366A1 Inhibitors of carnitine palmitoyltransferase and treating cancer |
| 09/18/2008 | CA2680360A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors |
| 09/18/2008 | CA2678897A1 Dibenzo[b,f][1,4]oxazapine compounds |
| 09/17/2008 | EP1970375A1 Arylmethylene urea derivative and use thereof |
| 09/17/2008 | EP1970373A1 Alicyclic heterocyclic compound |
| 09/17/2008 | EP1970057A1 Process for the preparation of stable pharmaceutical compositions of 2-(R) - (1-(R)-(3, 5- bis (trifluoromethyl) phenyl) ethoxy)-3-(S)-(4-fluoro) phenyl-4-(3-(5-oxo-1H, 4H-1, 2, 4-triazolo) methylmorpholine (aprepitant) |
| 09/17/2008 | EP1968973A2 Aryl-isoxazol-4-yl-imidazole derivatives |
| 09/17/2008 | EP1968972A1 Aryl-isoxazolo-4-yl-oxadiazole derivatives |
| 09/17/2008 | EP1968969A2 Organic compounds |
| 09/17/2008 | EP1968947A1 Gaba-b receptor modulators |
| 09/17/2008 | EP1968940A1 3 , 5-substitued piperidine compounds as renin inhibitors |
| 09/17/2008 | EP1732892B1 Tetrahydrocarbazoles and derivatives |
| 09/17/2008 | EP1495003B1 Fredericamycin derivatives |
| 09/17/2008 | EP1447400B1 Bicyclic compound |
| 09/17/2008 | EP1409477B1 Piperidine derivatives as nmda receptor antagonists |
| 09/17/2008 | EP1325910B1 Aliphatic nitrogenous five-membered ring compounds |
| 09/17/2008 | CN101268069A Phenyl- and pyridyl-i,2,4 -oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| 09/17/2008 | CN101268068A Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
| 09/17/2008 | CN101268067A Indol-3-yl-carbonyl-piperidin-benzoimidazole derivatives as V1A receptor antagonists |
| 09/17/2008 | CN101268064A Pyrazine derivatives useful as adenosine receptor antagonists |
| 09/17/2008 | CN101268060A Thiazolinones and oxazolinones and their use as PTP1B inhibitors |
| 09/17/2008 | CN101268059A 2-substituted hydroxylaminopyrimidine, method for the production and the use thereof in the form of pesticides |
| 09/17/2008 | CN101268046A Carboxamide derivatives as muscarinic receptor antagonists |
| 09/17/2008 | CN101268043A Amino-alkyl-amide derivatives as CCR3 receptor ligands |
| 09/17/2008 | CN101265258A Organic material and application thereof in organic electroluminescence device |
| 09/17/2008 | CN101265256A Tetraphenyvinyldicarbazole compound and preparation method thereof |
| 09/17/2008 | CN101265255A Method for preparing benzoxazine intermediate containing triazine structure |
| 09/17/2008 | CN100418955C Novel Benzo-fused heterocycles |
| 09/17/2008 | CN100418951C Cycloamine derivative and its use as medicine |
| 09/16/2008 | US7425637 mitogen-activated protein/extracellular signal-regulated (MAP/ERK)Kinase pathways; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide; hyperproliferative diseases; anticarcinogenic and antiinflammatory agent |
| 09/16/2008 | US7425631 Compounds and methods of use |
| 09/16/2008 | US7425564 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus prolifertor receptor and medicinal composition containing the same |
| 09/16/2008 | US7425561 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 09/16/2008 | US7425557 Inhibitors of glycogen synthase kinase 3 |
| 09/16/2008 | US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 09/16/2008 | US7425554 1,2-di(cyclic)substituted benzene compounds |
| 09/16/2008 | US7425553 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 09/16/2008 | US7425550 Lactam glycogen phosphorylase inhibitors and method of use |
| 09/16/2008 | CA2427221C Process and intermediates for preparing anti-cancer compounds |
| 09/12/2008 | WO2008109702A1 Compounds and compositions as modulators of gpr119 activity |
| 09/12/2008 | WO2008109314A1 Heterocyclic compounds, compositions comprising them and methods of their use |
| 09/12/2008 | WO2008109179A1 Metalloprotease inhibitors containing a squaramide moiety |
| 09/12/2008 | WO2008109178A1 Metalloprotease inhibitors containing a squaramide moiety |
| 09/12/2008 | WO2008108445A1 Benzoxazepine derivatives and use thereof |
| 09/12/2008 | WO2008108380A2 Pyrrole compounds |